Skip to main content
SpringerLink
Log in

The Effects of Ketamine Vary Among Inbred Mouse Strains and Mimic Schizophrenia for the P80, but not P20 or N40 Auditory ERP Components

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

N-methyl-D-aspartate (NMDA) antagonists produce behavioral and electrophysiological effects similar to schizophrenia. The mouse P20, N40, and P80 event related potential (ERP) components were analyzed for genetic variance among inbred strains and ketamine-induced differences to model abnormalities in the P50, N100, and P200 in schizophrenia. Ketamine increased P20/N40 amplitude and decreased P80 amplitude. Therefore, the effects of ketamine in mice are inconsistent with alterations in the corresponding P50 and N100 in schizophrenia, suggesting that NMDA receptor dysfunction may not underlie abnormalities of these components in schizophrenia. However, the effects of ketamine on the mouse P80 were consistent with P200 ERP changes in schizophrenia and support the hypothesis that NMDA dysfunction may contribute to some neuronal abnormalities in schizophrenia. The current study lays the groundwork for defining the role of NMDA-mediated transmission for specific aspects of neuronal processing that vary with genetic background. Future studies could use transcription profiling to clarify such interactions between genetic background, specific neuronal circuits, and transmitter systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boutros, N. N., Belger, A., Campbell, D., D'Souza, C., and Krystal, J. 1999. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res. 88(2):119–30.

    PubMed  Google Scholar 

  2. Catts, S. V., Shelley, A. M., Ward, P. B., Liebert, B., McConaghy, N., Andrews, S., and Michie, P. T. 1995. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am. J. Psychiatry 152(2):213–9.

    PubMed  Google Scholar 

  3. Freedman, R., Adler, L. E., Waldo, M. C., Pachtman, E., and Franks, R. D. 1983. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol. Psychiatry 18(5):537–51.

    PubMed  Google Scholar 

  4. Javitt, D. C., Doneshka, P., Zylberman, I., Ritter, W., and Vaughan, H. G., Jr. 1993. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol. Psychiatry 33(7):513–9.

    PubMed  Google Scholar 

  5. Mathalon, D. H., Ford, J. M., and Pfefferbaum, A. 2000. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study. Biol. Psychiatry 47(5):434–49.

    PubMed  Google Scholar 

  6. Shelley, A. M., Ward, P. B., Catts, S. V., Michie, P. T., Andrews, S., and McConaghy, N. 1991. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol. Psychiatry 30(10):1059–62.

    PubMed  Google Scholar 

  7. Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., and Freedman, R. 1992. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol. Psychiatry 32(7):607–16.

    PubMed  Google Scholar 

  8. Freedman, R., Adler, L. E., Bickford, P., Byerley, W., Coon, H., Cullum, C. M., Griffith, J. M., Harris, J. G., Leonard, S., Miller, C., and et al. 1994. Schizophrenia and nicotinic receptors. Harvard Review of Psychiatry 2(4):179–92.

    PubMed  Google Scholar 

  9. Siegel, C., Waldo, M., Mizner, G., Adler, L. E., and Freedman, R. 1984. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry 41(6):607–12.

    PubMed  Google Scholar 

  10. Javitt, D. C., Steinschneider, M., Schroeder, C. E., and Arezzo, J. C. 1996. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. USA 93(21):11962–7.

    PubMed  Google Scholar 

  11. Leonard, S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P., Byerley, W., Coon, H., Griffith, J. M., Miller, C., Myles-Worsley, M., Nagamoto, H. T., Rollins, Y., Stevens, K. E., Waldo, M., and Freedman, R. 1996. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22(3):431–45.

    PubMed  Google Scholar 

  12. Pincze, Z., Lakatos, P., Rajkai, C., Ulbert, I., and Karmos, G. 2001. Separation of mismatch negativity and the N1 wave in the auditory cortex of the cat: a topographic study. Clin. Neurophysiol. 112(5):778–84.

    PubMed  Google Scholar 

  13. Ruusuvirta, T. 1999. From spatial acoustic changes to attentive behavioral responses within 200 ms in humans. Neurosci. Lett. 275(1):49–52.

    PubMed  Google Scholar 

  14. Bullock, A. E., Slobe, B. S., Vazquez, V., and Collins, A. C. 1997. Inbred mouse strains differ in the regulation of startle and prepulse inhibition of the startle response. Behav. Neurosci. 111(6):1353–60.

    PubMed  Google Scholar 

  15. d'Amato, T., Karoumi, B., Rosenfeld, F., Saoud, M., Brunon, A. M., and Dalery, J. 1999. [Vulnerability to schizophrenia. II: Familial status of auditory evoked potential abnormalities]. Encephale 25(4):288–95.

    PubMed  Google Scholar 

  16. Stevens, K. E., Freedman, R., Collins, A. C., Hall, M., Leonard, S., Marks, M. J., and Rose, G. M. 1996. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and α-bungerotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15(2):152–162.

    PubMed  Google Scholar 

  17. Duncan, G. E., Miyamoto, S., Leipzig, J. N., and Lieberman, J. A. 1999. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res. 843(1-;2):171–83.

    PubMed  Google Scholar 

  18. Etienne, P. and Baudry, M. 1990. Role of excitatory amino acid neurotransmission in synaptic plasticity and pathology. An integrative hypothesis concerning the pathogenesis and evolutionary advantages of schizophrenia-related genes. J Neural. Transm. Suppl. 29:39–48.

    PubMed  Google Scholar 

  19. Kerwin, R., Patel, S., and Meldrum, B. 1990. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39(1):25–32.

    PubMed  Google Scholar 

  20. McCarley, R. W., Faux, S. F., Shenton, M. E., Nestor, P. G., and Adams, J. 1991. Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology. Schizophr. Res. 4(2):209–31.

    PubMed  Google Scholar 

  21. Javitt, D. C. and Zukin, S. R. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148(10):1301–8.

    PubMed  Google Scholar 

  22. Lahti, A. C., Weiler, M. A., Tamara Michaelidis, B. A., Parwani, A., and Tamminga, C. A. 2001. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25(4):455–67.

    PubMed  Google Scholar 

  23. Newcomer, J. W., Farber, N. B., Jevtovic-Todorovic, V., Selke, G., Melson, A. K., Hershey, T., Craft, S., and Olney, J. W. 1999. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20(2):106–18.

    PubMed  Google Scholar 

  24. Vollenweider, F. X., Vontobel, P., Oye, I., Hell, D., and Leenders, K. L. 2000. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J. Psychiatr. Res. 34(1):35–43.

    PubMed  Google Scholar 

  25. Abi-Dargham, A., Laruelle, M., Lipska, B., Jaskiw, G. E., Wong, D. T., Robertson, D. W., Weinberger, D. R., and Kleinman, J. E. 1993. Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala. Brain Res. 616(1-;2):53–7.

    PubMed  Google Scholar 

  26. Krystal, J. H., Karper, L. P., Bennett, A., D'Souza, D. C., Abi-Dargham, A., Morrissey, K., Abi-Saab, D., Bremner, J. D., Bowers, M. B. Jr., Suckow, R. F., Stetson, P., Heninger, G. R., and Charney, D. S. 1998. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl) 135(3):213–29.

    Google Scholar 

  27. Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., and Javitt, D. C. 2000. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen. Psychiatry 57(12):1139–47.

    PubMed  Google Scholar 

  28. Oranje, B., van Berckel, B. N., Kemner, C., van Ree, J. M., Kahn, R. S., and Verbaten, M. N. 2000. The effects of a sub-anaesthetic dose of ketamine on human selective attention. Neuropsychopharmacology 22(3):293–302.

    PubMed  Google Scholar 

  29. Jessen, F., Fries, T., Kucharski, C., Nishimura, T., Hoenig, K., Maier, W., Falkai, P., and Heun, R. 2001. Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia. Neurosci. Lett. 309(3):185–8.

    PubMed  Google Scholar 

  30. al-Amin, H. A. and Schwarzkopf, S. B. 1996. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia. Biol. Psychiatry 40(8):744–54.

    PubMed  Google Scholar 

  31. Bakshi, V. P. and Geyer, M. A. 1999. Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats. Physiol. Behav. 67(3):385–92.

    PubMed  Google Scholar 

  32. de Bruin, N. M., Ellenbroek, B. A., Cools, A. R., Coenen, A. M.,and van Luijtelaar, E. L. 1999. Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats. Psychopharmacology (Berl) 142(1):9–17.

    Google Scholar 

  33. Duncan, E. J., Madonick, S. H., Parwani, A., Angrist, B., Rajan, R., Chakravorty, S., Efferen, T. R., Szilagyi, S., Stephanides, M., Chappell, P. B., Gonzenbach, S., Ko, G. N., and Rotrosen, J. P. 2001. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25(1):72–83.

    PubMed  Google Scholar 

  34. Furuya, Y. and Ogura, H. 1997. Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition. Pharmacol. Biochem. Behav. 57(4):909–13.

    PubMed  Google Scholar 

  35. Martinez, Z. A., Halim, N. D., Oostwegel, J. L., Geyer, M. A., and Swerdlow, N. R. 2000. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharmacol. Biochem. Behav. 65(3):449–57.

    PubMed  Google Scholar 

  36. van Berckel, B. N., Oranje, B., van Ree, J. M., Verbaten, M. N., and Kahn, R. S. 1998. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. Psychopharmacology (Berl) 137(3):271–81.

    Google Scholar 

  37. LaBossiere, E. and Glickstein, M. 1976. Histological processing for the neural science. Charles C. Thomas, Springfield, pp. 41–43.

    Google Scholar 

  38. Siegel, S. J., Connolly, P., Liang, Y., Lenox, R. H., Gur, R. E., Bilker, W. B., Kanes, S. J., and Turetsky, B. I. 2003. Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 28(4):675–82.

    PubMed  Google Scholar 

  39. Connolly, P. M., Maxwell, C. R., Kanes, S. J., Abel, T., Liang, Y., Tokarczyk, J., Bilker, W. B., Turetsky, B. I., Gur, R. E., and Siegel, S. J. 2003. Auditory evoked potentials, startle and pre-pulse inhibition in DBA/2J and DBA/2Hsd inbred mouse sub-strains. Brain Res. 992(1):85–95.

    PubMed  Google Scholar 

  40. Umbricht, D. S., Latanov, A., Vissotksi, D., Nitsch, R., and Lipp, H. P. 2002. Development of a mouse model of deficits in prettentive auditory processing in schizophrenia. Biol. Psychiatry 51(8S):64S.

    Google Scholar 

  41. Maxwell, C. R., Liang, Y., Weightman, B. D., Kanes, S. J., Abel, T., Gur, R. E., Turetsky, B. I., Bilker, W. B., Lenox, R. H., and Siegel, S. J. 2004. Effects of chronic olanzapine and haloperidol differ on the mouse N1 auditory evoked potential. Neuropsychopharmacology.

  42. Cook, J. D., Ellinwood, E. H. Jr., and Wilson, W. P. 1968. Auditory habituation at primary cortex as a function of stimulus rate. Exp. Neurol. 21(2):167–75.

    PubMed  Google Scholar 

  43. Stevens, K. E., Johnson, R. G., and Rose, G. M. 1997. Rats reared in social isolation show schizophrenia-like changes in auditory gating. Pharmacol. Biochem. Behav. 58(4):1031–6.

    PubMed  Google Scholar 

  44. Stevens, K. E., Luthman, J., Lindqvist, E., Johnson, R. G., and Rose, G. M. 1996. Effects of neonatal dopamine depletion on sensory inhibition in the rat. Pharmacol. Biochem. Behav. 53(4):817–23.

    PubMed  Google Scholar 

  45. Stevens, K. E., Bullock, A. E., and Collins, A. C. 2001. Chronic corticosterone treatment alters sensory gating in C3H mice. Pharmacol. Biochem. Behav. 69(3-;4):359–66.

    PubMed  Google Scholar 

  46. Stevens, K. E., Kem, W. R., and Freedman, R. 1999. Selective alpha 7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice. Biol. Psychiatry 46(10):1443–50.

    PubMed  Google Scholar 

  47. Stevens, K. E., Kem, W. R., Mahnir, V. M., and Freedman, R. 1998. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) 136(4):320–7.

    Google Scholar 

  48. Stevens, K. E., Meltzer, J., and Rose, G. M. 1995. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats. Psychopharmacology (Berl) 119(2):163–70.

    Google Scholar 

  49. Stevens, K. E. and Wear, K. D. 1997. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol. Biochem. Behav. 57(4):869–74.

    PubMed  Google Scholar 

  50. de Bruin, N. M., Ellenbroek, B. A., van Schaijk, W. J., Cools, A. R., Coenen, A. M., and van Luijtelaar, E. L. 2001. Sensory gating of auditory evoked potentials in rats: effects of repetitive stimulation and the interstimulus interval. Biol. Psychol. 55(3):195–213.

    PubMed  Google Scholar 

  51. Kreitschmann-Andermahr, I., Rosburg, T., Demme, U., Gaser, E., Nowak, H., and Sauer, H. 2001. Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res. Cogn. Brain Res. 12(1):109–16.

    PubMed  Google Scholar 

  52. Shelley, A. M., Silipo, G., and Javitt, D. C. 1999. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophr. Res. 37(1):65–79.

    PubMed  Google Scholar 

  53. Ogura, C., Nageishi, Y., Matsubayashi, M., Omura, F., Kishimoto, A., and Shimokochi, M. 1991. Abnormalities in event-related potentials, N100, P200, P300 and slow wave in schizophrenia. Jpn. J. Psychiatry Neurol. 45(1):57–65.

    PubMed  Google Scholar 

  54. Geyer, M. A. 1998. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31 (Suppl 2):73–9.

    PubMed  Google Scholar 

  55. Ford, J. M., Roth, W. T., Menon, V., and Pfefferbaum, A. 1999. Failures of automatic and strategic processing in schizophrenia: comparisons of event-related brain potential and startle blink modification. Schizophr. Res. 37(2):149–63.

    PubMed  Google Scholar 

  56. Umbricht, D., Koller, R., Vollenweider, F. X., and Schmid, L. 2002. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol. Psychiatry 51(5):400–6.

    PubMed  Google Scholar 

  57. Javitt, D. C., Jayachandra, M., Lindsley, R. W., Specht, C. M., and Schroeder, C. E. 2000. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clin. Neurophysiol. 111(5):833–6.

    PubMed  Google Scholar 

  58. Ehlers, C. L., Kaneko, W. M., Wall, T. L., and Chaplin, R. I. 1992. Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPS) in rats. Neuropharmacology 31(4):369–78.

    PubMed  Google Scholar 

  59. Roth, W. T., Pfefferbaum, A., Kelly, A. F., Berger, P. A., and Kopell, B. S. 1981. Auditory event-related potentials in schizophrenia and depression. Psychiatry Res. 4(2):199–212.

    PubMed  Google Scholar 

  60. Kroner, S., Schall, U., Ward, P. B., Sticht, G., Banger, M., Haffner, H. T., and Catts, S. V. 1999. Effects of prepulses and d-amphetamine on performance and event-related potential measures on an auditory discrimination task. Psychopharmacology (Berl) 145(2):123–32.

    Google Scholar 

  61. Weiner, I. 2003. The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl). 169(3/4):257–297.

    Google Scholar 

  62. Ito, C. 2002. Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. Curr. Pharm. Des. 8(2):147–53.

    PubMed  Google Scholar 

  63. Ralph, R. J., Varty, G. B., Kelly, M. A., Wang, Y. M., Caron, M. G., Rubinstein, M., Grandy, D. K., Low, M. J., and Geyer, M. A. 1999. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J. Neurosci. 19(11):4627–33.

    PubMed  Google Scholar 

  64. Jansen, K. L. and Darracot-Cankovic, R. 2001. The nonmedical use of ketamine, part two: a review of problem use and dependence. J. Psychoactive Drugs 33(2):151–8.

    PubMed  Google Scholar 

  65. Hemby, S. E., Ginsberg, S. D., Brunk, B., Arnold, S. E., Trojanowski, J. Q., and Eberwine, J. H. 2002. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen. Psychiatry 59(7):631–40.

    PubMed  Google Scholar 

  66. Vysokanov, A., Flores-Hernandez, J., and Surmeier, D. J. 1998. mRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons. Neurosci. Lett. 258(3):179–82.

    PubMed  Google Scholar 

  67. Simosky, J. K., Stevens, K. E., Kem, W. R., and Freedman, R. 2001. Intragastric DMXB-A, an alpha7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice. Biol. Psychiatry 50(7):493–500.

    PubMed  Google Scholar 

  68. Simosky, J. K., Stevens, K. E., Adler, L. E., and Freedman, R. 2003. Clozapine improves deficient inhibitory auditory processing in DBA/2 mice, via a nicotinic cholinergic mechanism. Psychopharmacology (Berl) 165(4):386–96.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanley Center for Experimental Therapeutics, Division of Neuropsychiatry, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

    Patrick M. Connolly, Christina Maxwell, Yuling Liang, Jonathan B. Kahn & Steven J. Siegel

  2. Division of Neuropsychiatry, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

    Patrick M. Connolly, Christina Maxwell, Yuling Liang, Jonathan B. Kahn, Stephen J. Kanes, Raquel E. Gur, Bruce I. Turetsky & Steven J. Siegel

  3. Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania

    Ted Abel

  4. Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

    Steven J. Siegel

Authors
  1. Patrick M. Connolly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina Maxwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuling Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan B. Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stephen J. Kanes
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ted Abel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Raquel E. Gur
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bruce I. Turetsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Steven J. Siegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Connolly, P.M., Maxwell, C., Liang, Y. et al. The Effects of Ketamine Vary Among Inbred Mouse Strains and Mimic Schizophrenia for the P80, but not P20 or N40 Auditory ERP Components. Neurochem Res 29, 1179–1188 (2004). https://doi.org/10.1023/B:NERE.0000023605.68408.fb

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:NERE.0000023605.68408.fb

Search

Navigation